Voya Investment Management LLC Fate Therapeutics Inc Transaction History
Voya Investment Management LLC
- $78.9 Billion
- Q4 2024
A detailed history of Voya Investment Management LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Voya Investment Management LLC holds 31,259 shares of FATE stock, worth $28,758. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,259
Previous 33,434
6.51%
Holding current value
$28,758
Previous $117,000
56.41%
% of portfolio
0.0%
Previous 0.0%
Shares
35 transactions
Others Institutions Holding FATE
# of Institutions
167Shares Held
101MCall Options Held
41.3KPut Options Held
15.9K-
Redmile Group, LLC San Francisco, CA12.9MShares$11.8 Million1.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$9.51 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$9.31 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.84MShares$4.45 Million0.16% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.38MShares$4.03 Million0.0% of portfolio
About FATE THERAPEUTICS INC
- Ticker FATE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,000,304
- Market Cap $89.2M
- Description
- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...